The recent round of $58 million in Series B financing was led by Johnson & Johnson Development Corp. and includes Mayo Clinic.
In 2010, the Nevro device received CE mark approval in Europe for chronic leg and back pain.
Read the Mass Device report on Nevro.
Related Articles on Pain Management Devices:
Medtronic Issues Warning for SynchroMed II Implantable Painkiller Pumps
Impact on Pain Management of the New Outcomes Research Institute: Q&A With Dr. Laxmaiah Manchikanti
NIH Identifies 4 Key Areas for Record Amount of Pain Research Funding
